[Circulating immune complexes and anti-IgG antibodies in rheumatoid disease. Value of C3d assay]. 1981

B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D015933 Complement C3d A 302-amino-acid fragment in the alpha chain (672-1663) of C3b. It is generated when C3b is inactivated (iC3b) and its alpha chain is cleaved by COMPLEMENT FACTOR I into C3c, and C3dg (955-1303) in the presence COMPLEMENT FACTOR H. Serum proteases further degrade C3dg into C3d (1002-1303) and C3g (955-1001). C3d Complement,Complement 3d,Complement C3d Fragment,Complement Component 3d,C3d Fragment, Complement,C3d, Complement,Complement, C3d,Component 3d, Complement,Fragment, Complement C3d

Related Publications

B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
March 1980, The American journal of tropical medicine and hygiene,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
January 2009, Scandinavian journal of gastroenterology,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
January 1994, Bulletin du Groupement international pour la recherche scientifique en stomatologie & odontologie,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
October 1982, Immunology,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
January 1970, Acta rheumatologica Scandinavica,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
September 1984, Clinical chemistry,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
July 1979, Kidney international,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
January 1993, Neoplasma,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
February 2009, Immunology letters,
B Duquesnoy, and F Santoro, and J L Siame, and P Vanhille, and B Raviart, and P Wattre, and V Lemaitre, and P Y Hatron
January 1979, Rheumatology and rehabilitation,
Copied contents to your clipboard!